Cargando…

Mid-Regional Pro-Adrenomedullin and N-Terminal Pro-B-Type Natriuretic Peptide Measurement: A Multimarker Approach to Diagnosis and Prognosis in Acute Heart Failure

Background: Acute heart failure (AHF) is a major cause of hospitalization and mortality worldwide. Early and accurate diagnosis, as well as effective risk stratification, are essential for optimizing clinical management and improving patient outcomes. In this context, biomarkers have gained increasi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spoto, Silvia, Argemi, Josepmaria, Di Costanzo, Roberta, Gavira Gomez, Juan Josè, Salterain Gonzales, Nahikari, Basili, Stefania, Cangemi, Roberto, Abbate, Antonio, Locorriere, Luciana, Masini, Francesco, Testorio, Giulia, Calarco, Rodolfo, Battifoglia, Giulia, Mangiacapra, Fabio, Fogolari, Marta, Costantino, Sebastiano, Angeletti, Silvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381388/ https://www.ncbi.nlm.nih.gov/pubmed/37511766 http://dx.doi.org/10.3390/jpm13071155

Ejemplares similares

Synergistic effect of myocardial injury and mid-regional proAdrenomedullin elevation in determining clinical outcomes of SARS-CoV-2 patients
por: Spoto, Silvia, et al.
Publicado: (2022)

Active Surveillance Cultures and Procalcitonin in Combination With Clinical Data to Guide Empirical Antimicrobial Therapy in Hospitalized Medical Patients With Sepsis
por: Spoto, Silvia, et al.
Publicado: (2022)

Diagnostic Accuracy and Prognostic Value of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Septic Patients outside the Intensive Care Unit
por: Spoto, Silvia, et al.
Publicado: (2021)

Best diagnostic accuracy of sepsis combining SIRS criteria or qSOFA score with Procalcitonin and Mid-Regional pro-Adrenomedullin outside ICU
por: Spoto, Silvia, et al.
Publicado: (2020)

Pro-adrenomedullin as prognostic biomarker in the sepsis
por: De La Torre-Prados, M, et al.
Publicado: (2013)

Prognostic value of pro-adrenomedullin and copeptin in acute infective endocarditis
por: Zampino, Rosa, et al.
Publicado: (2021)

High value of mid‐regional proadrenomedullin in COVID‐19: A marker of widespread endothelial damage, disease severity, and mortality
por: Spoto, Silvia, et al.
Publicado: (2021)

Prognostic value of pro-atrial natriuretic peptide, pro-adrenomedullin, and pro-endothelin-1 in critically ill patients
por: Bloos, F, et al.
Publicado: (2006)

Pro-adrenomedullin as a clinical predictor after cardiac surgery
por: Van Fessem, J, et al.
Publicado: (2013)

Systemic lupus erythematosus myocarditis after COVID-19 vaccination
por: Sogbe, Miguel, et al.
Publicado: (2023)

Systemic lupus erythematosus myocarditis after COVID-19 vaccination
por: Sogbe, Miguel, et al.
Publicado: (2023)

Single pro-adrenomedullin determination in septic shock and 28-day mortality
por: Garcia-de la Torre, A, et al.
Publicado: (2014)

The Role of Adrenomedullin in the Renal NADPH Oxidase and (Pro)renin in Diabetic Mice
por: Hayashi, Michio, et al.
Publicado: (2013)

Mid-Regional Pro-Adrenomedullin (MR-proADM) as a Biomarker for Sepsis and Septic Shock: Narrative Review
por: Önal, Uğur, et al.
Publicado: (2018)

Pro-atrial natriuretic peptide and pro-adrenomedullin before cardiac surgery in children. Can we predict the future?
por: Bobillo-Perez, Sara, et al.
Publicado: (2020)

Plasma levels of pro-atrial natriuretic peptide, pro-adrenomedullin, and pro-endothelin-1 correlate with the severity of organ dysfunction in critically ill patients
por: Bloos, F, et al.
Publicado: (2006)

Mid regional pro-adrenomedullin for the prediction of organ failure in infection. Results from a single centre study
por: Viaggi, Bruno, et al.
Publicado: (2018)

The Association of Mid-Regional Pro-Adrenomedullin and Mid-Regional Pro-Atrial Natriuretic Peptide with Mortality in an Incident Dialysis Cohort
por: Gouya, Ghazaleh, et al.
Publicado: (2011)

Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study
por: Christ-Crain, Mirjam, et al.
Publicado: (2005)

Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]
por: Christ-Crain, Mirjam, et al.
Publicado: (2006)

Plasma Midregional Pro-Adrenomedullin Improves Prediction of Functional Outcome in Ischemic Stroke
por: Seifert-Held, Thomas, et al.
Publicado: (2013)

Diffuse maculopapular rash: A family cluster during the last Chikungunya virus epidemic in Italy
por: Spoto, Silvia, et al.
Publicado: (2018)

Diagnostic and prognostic usefulness of mid-regional pro-adrenomedullin levels in patients with severe sepsis
por: Valenzuela Sanchez, F, et al.
Publicado: (2015)

Mid-Regional Pro-Adrenomedullin as a Prognostic Factor for Severe COVID-19 ARDS
por: de Montmollin, Etienne, et al.
Publicado: (2022)

Plasma mid‐regional pro‐adrenomedullin: A biomarker of the ischemic penumbra in hyperacute stroke
por: Ishiyama, Hiroyuki, et al.
Publicado: (2022)

Pro-adrenomedullin, pro-endothelin-1, procalcitonin, C-reactive protein and mortality risk in critically ill children: a prospective study
por: Rey, Corsino, et al.
Publicado: (2013)

Visceral leishmaniasis triggering an adult‐onset Still's disease: a unique case
por: Spoto, Silvia, et al.
Publicado: (2017)

Mid-regional pro-adrenomedullin (MR-proADM), a marker of positive fluid balance in critically ill patients: results of the ENVOL study
por: Vigué, Bernard, et al.
Publicado: (2016)

Prognostic value of mid-regional pro-adrenomedullin (MR-proADM) in patients with community-acquired pneumonia: a systematic review and meta-analysis
por: Liu, Dan, et al.
Publicado: (2016)

Copeptin, pro-atrial natriuretic peptide and pro-adrenomedullin as markers of hypoxic stress in patients with obstructive sleep apnea—a prospective intervention study
por: Karakioulaki, Meropi, et al.
Publicado: (2021)

Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study
por: Montrucchio, Giorgia, et al.
Publicado: (2021)

The evaluation of the clinical utility of urocortin 1 and adrenomedullin versus proBNP in systolic heart failure
por: Yıldırım, Erkan, et al.
Publicado: (2017)

Pooled analysis of mid-regional pro-adrenomedullin values in COVID-19 patients with critical illness
por: Lippi, Giuseppe, et al.
Publicado: (2021)

Influenza B virus infection complicated by life-threatening pericarditis: a unique case-report and literature review
por: Spoto, Silvia, et al.
Publicado: (2019)

Pro-adrenomedullin usefulness in the management of children with community-acquired pneumonia, a preliminar prospective observational study
por: Sardà Sánchez, Marta, et al.
Publicado: (2012)

Mid-regional pro-adrenomedullin and lactate levels for risk stratification in patients with out-of-hospital cardiac arrest
por: Zelniker, Thomas A, et al.
Publicado: (2023)

Use of sacubitril/valsartan in Marfan syndrome–related cardiomyopathy: The first case report
por: Spoto, Silvia, et al.
Publicado: (2019)

The value of plasma pro-enkephalin and adrenomedullin for the prediction of sepsis-associated acute kidney injury in critically ill patients
por: Liu, Ruijin, et al.
Publicado: (2020)

Endothelial dysfunction and Mid-Regional proAdrenomedullin: What role in SARS-CoV-2 infected Patients?
por: Zaninotto, Martina, et al.
Publicado: (2021)

Plasma Concentrations of the Vasoactive Peptide Fragments Mid-Regional Pro-Adrenomedullin, C-Terminal Pro-Endothelin 1 and Copeptin in Hemodialysis Patients: Associated Factors and Prediction of Mortality
por: Artunc, Ferruh, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vdcdi84uniqbqbot49ecfqf5g4